Metabolic Dysfunctions
development of chronic metabolic diseases
Pharmacological Treatment of Schizophrenia TREATMENT
training of young scientists
high-level training
life long health-care interventions
mental health research
adverse secondary metabolic effects of drugs
short-term antipsychotic drug responses impact long-term metabolic control
risk evaluation of drug
effective treatment regimens
predictive value
current severe limitations of health care interventions
life-long medications
Marie Sklodowska Curie Innovative Training Network proposal
design of predictive marker kits
mental disorders
tool design
European Network
commercial value
trans-national employability of young scientists
strong negative impact
implementation of personalized medicine tools
product
strategies
career paths
need
intersectorial
metabolism
pharmacology
private sectors
capabilities
program
ambitious strategy
relevant aspect
multidisciplinary knowledge
biomarkers
traditional toxicology studies
validation
patients
well-being
ultimate goal
treatments
medical practice
effort
adherence